Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1- infected long-term survivors

AIDS Research and Human Retroviruses

Volumn 15, Issue 13, 1999, Pages 1219-1228

  Betts, Michael R ^a   Krowka, John F ^b   Kepler, Thomas B ^c   Davidian, Marie ^c   Christopherson, Cindy ^d   Kwok, Shirley ^d   Louie, Leslie ^e   Eron, Joseph ^f   Sheppard, Haynes ^b   Frelinger, Jeffrey A ^a,f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; ENVELOPE PROTEIN; GAG PROTEIN; LAMIVUDINE; PROTEINASE INHIBITOR; STAVUDINE; VIRUS PROTEIN; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; VIRUS LOAD; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENE PRODUCTS, POL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; RECEPTORS, CCR5; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 0033198537     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310313     Document Type: Article

References (44)

1. + T-cell levels. AIDS 1993;7:1159-1166.
2. + lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:496-505.
3. Haynes BF, Pantaleo G, and Fauci AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-328.
4. Connor RI, Sheridan KE, Lai C, Zhang L, and Ho DD: Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1996;70:5306-5311.
5. Wang WK, Essex M, McLane MF, Mayer KH, Hsieh CC, Brumblay HG, Seage G, and Lee TH: Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 1996;93: 6693-6697.
6. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
7. Connor RI, Sheridan KE, Ceradini D, Choe S, and Landau NR: Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-628.
8. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270: 988-991.
9. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien, SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, and Mann DL: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:405-411.
10. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
11. Michael NL, Louie LG, Rohrbaugh AL, Schultz KA, Dayhoff DE, Wang CE. and Sheppard HW: The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med 1997;3:1160-1162.
12. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, and O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277: 959-965.
13. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68: 4650-4655.
14. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
15. Vesanen M, Stevens CE, Taylor PE, Rubinstein P, and Saksela K: Stability in controlling viral replication identifies long-term non-progressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol 1996;70:9035-9040.
16. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, and Shaw GM: , Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-211.
17. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, and Walker BD: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HTV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 1996;156:2616-2623.
18. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, and Rowland-Jones S: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212-217.
19. + T cell responses associated with control of viremia. Science 1997;278:1447-1450.
20. Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR Jr, Gorman, MO, Detels R, Taylor E, Phair JP, and Margolick JB: Virologie and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:448-455.
21. Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Root M, Kuiken CL, and Goudsmit J: Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Virology 1994;201:285-293.
22. Rinaldo C, Huang XL, Fan ZF, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebmann J, Cottrill M, et al.: High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-5842.
23. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, Eeftinck-Schattenkerk JK, Osterhaus AD, Schuitemaker H, and Miedema F: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
24. Harrer E, Harrer T, Buchbinder S, Mann DL, Feinberg M, Yilma T, Johnson RP, and Walker BD: HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res Hum Retroviruses 1994;10:S77-S78.
25. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, and Walker BD: Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type 1 infection. AIDS Res Hum Retroviruses 1996;12:585-592.
26. Earl PL, Cooper N, and Moss B: Preparation of cell cultures and vaccinia virus stocks. In: Current Protocols in Molecular Biology (Ausubel FM, ed.), Vol. 2. John Wiley & Sons, New York, 1993, pp. 16.16.1-16.16.7.
27. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, and Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32: 292-300.
28. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, and Sheppard HW: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-340.
29. Krausa P, Bodmer JG, and Browning MJ: Defining the common subtypes of HLA A9, A10, A28, and A19 by use of ARMS/PCR. Tissue Antigens 1993;42:91-99.
30. Sadler AM, Petronzelli F, Krausa P, Marsh SG, Guttridge MG, Browning MJ, and Bodmer J: Low resolution DNA typing for HLA-B using sequence specific primers in allele- or group-specific ARMS/PCR. Tissue Antigens 1994;44:148-154.
31. Fernandez-Vina M, Lazaro AM, Sun Y, Miller S, Forero L, and Stastny P: Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 1995;45:153-168.
32. Nixon DF, Townsend AR. Elvin JG, Rizza CR, Gallwey J, and McMichael AJ: HIV-1 Gag-specific cytotoxic T lymphocytes defined with recumbinant vaccinia virus and synthetic peptides. Nature (London) 1988;336:484-487.
33. Laird NM and Ware JH: Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
34. Cao Y, Qin L, Zhang L, Safrit J. and Ho DD: Characterization of long-term survivors of human immunodeficiency virus type 1 infection. Immunol Lett 1996;51:7-13.
35. Musey L, Hughes J, Schacker T, Shea T, Corey L, and McElrath MJ: Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997;337:1267-1274.
36. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, and Sullivan JL: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo. J Infect Dis 1997;176:118-125.
37. Murali-Krishna K, Altman D, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, Slansky J, and Ahmed R: Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998;8:177-187.
38. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, and Schooley RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 1987;328:345-348.
39. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, and McMichael AJ: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
40. Korbel B, Koup R, Walker B, Haynes B, Moore J, and Myers G: HlV Molecular Immunological Database, 1995. http://hiv-web. lanl.gov/immunology/index.html
41. van der Burg SH, Klein MR, Pontesilli O, Holwerda AM, Drijfhout JW, Kast WM, Miedema F, and Melief CJ: HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS. J Immunol 1997;159:3648-3654.
42. + T cell numbers in progression 1998;14: 1423-1433.
43. Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolf F, Schuitemaker H, and Miedema F: Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: A predominant Gag-specific response is associated with nonprogressive infection. J Infect Dis 1998;178:1008-1018.
44. Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolf F, Schuitemaker H, and Miedema F: Kinetics of immune functions and virus replication during HIV-1 infection. Immunol Lett 1997; 57:125-130.